Expression of the Epidermal Growth Factor Seven-Transmembrane Member CD97 Correlates with Grading and Staging in Human Oral Squamous Cell Carcinomas
- Tarek Mustafa1,2,
- Alexander Eckert2,
- Thomas Klonisch6,
- Astrid Kehlen3,
- Peter Maurer2,
- Michael Klintschar4,
- Mabruk Erhuma3,
- Robby Zschoyan5,
- Oliver Gimm1,
- Henning Dralle1,
- Johannes Schubert2 and
- Cuong Hoang-Vu1
- 1Experimental and Oncological Surgery Research Group, University Department of General, Visceral, and Vascular Surgery; 2University Department of Oral, Maxillo, and Plastic Facial Surgery; 3Institute of Medical Immunology; 4Institute of Forensic Medicine; and 5University Department of Pediatric Surgery, Martin-Luther-University, Halle, Germany; 6Department of Human Anatomy and Cell Science, University of Manitoba, Canada USA
- Requests for reprints:
Cuong Hoang-Vu, AG Experimentelle Chirurgie und Onkologie, Martin-Luther-University Halle-Wittenberg, Magdeburger Straße 18, 06097 Halle, Germany. Phone: 49-345-557-1366; Fax: 49-345-557-1309. E-mail: hoang-vu{at}medizin.uni-halle.de
Abstract
Introduction: The oral squamous cell carcinoma (OSCC) is the sixth most common malignant tumor worldwide. No significant better progress has been made in the treatment of OSCCs during the last decades. The heterodimeric CD97 protein is a epidermal growth factor seven-transmembrane family member and was identified as a dedifferentiation marker in thyroid carcinomas. Nothing is known about CD97 in OSCCs.
Material and Methods: Employing UV-laser microdissection, CD97 and its ligand CD55 were investigated in normal oral mucosa and OSCCs (n = 78) by multiplex reverse transcription-PCR. Frozen sections were investigated by immunohistochemistry. The effects of retinoic acid and sodium butyrate on the CD97/CD55 expression in OSCC cell lines were determined by quantitative PCR, immunocytochemistry, and flow cytometry.
Results: Weak CD97 transcripts were expressed in normal mucosa and normal basal epithelial cells revealed specific CD97 immunostaining. Strong CD97 transcripts were detected in pT3/T4 and G3/G4 OSCC tissues, whereas pT1/T2 and G1/G2 carcinomas revealed weak CD97 transcript levels. A weak CD97 immunostaining was observed in pT1/T2 and G1/G2 tumors. By contrast, intensive CD97 immunostaining was detected in pT3/T4 OSCCs and G3/G4 lesions. CD55 gene expression was low in normal mucosa. All OSCCs, irrespective of stage and grading, displayed strong CD55 immunostaining. Sodium butyrate and retinoic acid inhibited CD97 mRNA and protein in OSCC cell lines. Interestingly, CD55 was up-regulated by both substances.
Conclusion: We identified CD97 as a novel marker of dedifferentiated OSCC. Interaction of CD97 and CD55 may facilitate adhesion of OSCC cells to surrounding surfaces that would result in metastases and bad prognosis.
Footnotes
-
Grant support:Pinguin stiftung (Düsseldorf, Germany).
-
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
- Accepted August 3, 2004.
- Received April 22, 2004.
- Revision received June 29, 2004.
